Biotech Startups

Innerspace is a health-tech company that helps pharmaceutical companies improve quality, efficiency, and compliance in aseptic manufacturing. Its Frame-by-Frame methodology captures industry knowledge to power data-driven digital solutions for process optimization, risk assessment, and training, including virtual reality-based cleanroom training.

3 investors

Dec Group provides end-to-end process technologies and equipment for powder handling, containment, and continuous manufacturing serving the pharmaceutical and chemical processing industries. The company operates internationally, with subsidiaries including Dec Continuous Process Ltd and Dec Brasil serving customers across Europe, South America, and beyond.

3 investors

Inocras is a bioinformatics company that uses whole genome sequencing and proprietary analytics to produce clinically actionable insights for patient diagnosis and treatment, operating a CLIA-certified and CAP-accredited lab. It serves patients, clinicians, and researchers with whole genome diagnostic testing, sequencing and interpretation services, genetic counseling, and clinical trial matching.

3 investors

Inoviv provides custom multiplexed LC-MS proteomics panels for biomarker discovery and analysis in drug discovery and development. The company delivers pre-validated mass spectrometry workflows with end-to-end support for research and clinical applications.

3 investors

InsideTracker provides personalized health insights by analyzing biological markers and genetic data to deliver customized recommendations for nutrition, fitness, and lifestyle optimization for individuals seeking longevity and preventive wellness.

3 investors

3 investors

inSoma Bio develops biomaterial products for reconstruction plastic surgery, enabling surgeons to use patients' own tissue instead of synthetic implants and fillers for breast and facial reconstruction procedures.

3 investors

Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform. The company focuses on common cancers with high unmet need through small molecules and biologics.

3 investors

Instil Bio is a biotechnology company that identifies and acquires or licenses therapeutic candidates for development, with a strategic focus on securing additional novel drug candidates targeting diseases with significant unmet medical needs. The company previously pursued cell therapies including a folate receptor alpha-targeted tumor infiltrating lymphocyte therapy before discontinuing its former lead bispecific antibody program in early 2026.

3 investors

3 investors

Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology. It operates an integrated drug discovery platform combining synthetic biology, chemical data, and machine learning.

3 investors

InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions. Its technology targets venous disease conditions such as postthrombotic syndrome that current therapies fail to address.

3 investors

Intrepid Labs applies active machine learning, robotics, and pharmaceutical science to accelerate the design and development of drug products and delivery formulations. It uses a closed-loop platform to develop next-generation therapeutics with improved properties and performance.

3 investors

Invenio develops rapid on-site tissue imaging systems combined with AI to improve cancer patient care. The company serves pathologists and oncologists with real-time diagnostic tools for cancer detection.

3 investors

Inventage Lab develops microfluidic-based drug-delivery platform technologies for long-acting injectables, high-concentration biologics, and gene and nucleic-acid therapeutics, offering control over particle uniformity and release kinetics along with scale-up to GMP manufacturing. It serves biopharmaceutical partners across the drug formulation and delivery cycle, from R&D through commercial production.

3 investors

IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.

3 investors

iQure Pharma is a biopharmaceutical company developing therapies aimed at restoring glutamate balance and reducing excitotoxicity in neurological disorders with high unmet need. It is run by a team of scientists, clinicians, and researchers.

3 investors

Irazú Oncology develops cancer immunotherapies using a proprietary Outer Membrane Vesicles (OMV) platform based on engineered bacterial nanoparticles that deliver cancer antigens. The biotech company, founded in 2022, is building a pipeline of immunotherapies for cancer patients.

3 investors

Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.

3 investors

Isabl develops whole genome and transcriptome sequencing technology for cancer diagnosis, delivering comprehensive genomic profiling and treatment options to physicians and research teams. The company provides rapid cancer diagnostic tests in clinically relevant timeframes to improve outcomes for cancer patients globally.

3 investors

Iterion Therapeutics is a clinical-stage biopharmaceutical company developing cancer therapies targeting the Wnt/β-catenin pathway. Its lead candidate is in clinical trials for advanced hepatocellular carcinoma and other Wnt-driven tumors such as colorectal cancer.

3 investors

Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens. The company's lead product, sulopenem (ORLYNVAH), has been approved by the FDA for treating uncomplicated urinary tract infections in adult women.

3 investors

ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio. The company manufactures and supplies medical radioisotopes including Lutetium-177 and Actinium-225 for cancer detection and treatment.

3 investors

Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors. The system is designed for nursing staff, pharmacists, IT departments, clinical engineers, and anesthesia professionals in healthcare facilities.

3 investors